Nutrition for Crohn’s Disease

Crohn’s disease represents a chronic, progressive inflammatory condition primarily affecting the gastrointestinal tract, with a particular predilection for the small and large intestines. Its prevalence has been steadily increasing over recent decades. While the precise etiology remains elusive, contemporary research implicates a multifactorial origin, with key contributing elements including: – immunological dysregulation resulting in autoimmune-mediated tissue damage, – alterations in the composition and function of the gut microbiome, – genetic predisposition supported by familial clustering studies, – environmental triggers such as dietary patterns, tobacco exposure, or chronic stress. The disease most commonly manifests between the ages of 16 and 25, though late-onset cases are also documented. Diagnostic protocols rely heavily on endoscopic evaluation with mucosal biopsy sampling for histopathological examination. A non-invasive surrogate marker, fecal calprotectin, serves as a valuable indicator—elevated levels correlate with active intestinal inflammation and ulcerative lesions. Clinical presentations typically include persistent diarrhea, recurrent abdominal pain of varying severity, and substantial unintentional weight loss. Due to the non-specific nature of these symptoms, diagnosis is frequently delayed, thereby increasing the risk of severe complications such as bowel obstruction, fistula formation, or malnutrition. Management of Crohn’s disease necessitates a prolonged, multidisciplinary approach focused on symptom alleviation and prevention of flare-ups. Although current therapeutic modalities—encompassing immunosuppressive pharmacotherapy, dietary modifications, and surgical interventions in advanced cases—can significantly enhance quality of life, they do not offer a definitive cure. Conversely, the absence of treatment may lead to disease progression with potentially life-threatening consequences. Given the profound impact on occupational performance, educational attainment, and social engagement, the implementation of a personalized treatment regimen is critical to optimizing patient functionality and mitigating symptom burden in daily life.